HIV TESTING AND STAGING, DISEASE PROGRESSION, AND MARKERS

被引：5

作者：

DAX, EM

机构：

[1] National HIV Reference Laboratory, Fairfield Hospital, Fairfield, Vic. 3078, Yarra Bend Road

来源：

CURRENT OPINION IN INFECTIOUS DISEASES | 1993年 / 6卷 / 02期

关键词：

D O I：

10.1097/00001432-199304000-00010

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The diagnosis of human immunodeficiency virus infection in technology-rich countries is accomplished by detection of anti-human immunodeficiency virus in serum with almost 100% sensitivity and specificity. The use of laboratory-based markers for monitoring disease prognosis and therapeutic efficacy is becoming highly sophisticated. Published and continuing studies demonstrate the validity of using various markers as well as the correlation between markers as indices of clinical prognosis and progress and outcome. Used quantitatively, markers may be used to monitor therapy. Exciting prospects for assessing an individual's antiviral resistance and tailoring therapy are on the horizon. However, diagnostic tests and tests for prognosis and management remain unavailable to many human immunodeficiency virus-infected people.

引用

页码：191 / 199

页数：9